Four-in-One Antibodies Have Superior Cancer Inhibitory Activity against EGFR, HER2, HER3, and VEGF through Disruption of HER/MET Crosstalk

2015

These results establish a new principle to achieve combined HER receptor inhibition and limit drug resistance using a single antibody.

Keywords:

References

Citations